Rapid ASPECTS

by RapidAI  · Based in United States → — Clinical AI Platform Enhancing Assessment & Care
Emergency Medicine Neurology Radiology

Annual subscription model; pricing varies by region, hospital type, modules, and imaging modalities. starts at approximately $12,000 for a single module in the united states.
Regulatory Status Disclosed

Overview

Rapid ASPECTS, developed by iSchemaView (now operating as RapidAI), is a computer-aided diagnosis (CADx) software device designed to assist clinicians in the assessment and characterization of brain tissue abnormalities using CT image data. It automatically registers images, segments, and analyzes ASPECTS (Alberta Stroke Program Early CT Score) Regions of Interest (ROIs). The software extracts image data for these ROIs to provide analysis and computer analytics based on morphological characteristics. An artificial intelligence algorithm then synthesizes these features into a single ASPECT Score. Rapid ASPECTS is indicated for the evaluation of adult patients presenting for diagnostic imaging workup with known Middle Cerebral Artery (MCA) or Internal Carotid Artery (ICA) occlusion, to assess the extent of disease. It provides information useful in characterizing early ischemic brain tissue injury during image interpretation, typically within 6 hours. The tool aims to improve clinician diagnostic accuracy, increase reader reliability, and reduce intra-reader variability, ultimately helping physicians make faster clinical decisions for patients with large vessel occlusions (LVOs) and determine eligibility for thrombectomy.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated ASPECTS score generation for non-contrast CT scans
  • Visualization of regions of asymmetry and ischemic change
  • Improved clinician diagnostic accuracy (shown to improve by 10%)
  • Increased reader reliability and reduced intra-reader variability
  • Fast results delivery (under 2 minutes)
  • Assists in determining thrombectomy eligibility
  • Utilizes clinically validated machine-learning algorithms
  • Creates high-quality images from non-contrast CT studies
  • Delivers results via PACS, email, and mobile/web applications
  • Provides comparative analysis to the ASPECTS standard of care radiologist assessment

Use Cases

  • Assessment and characterization of brain tissue abnormalities using CT image data
  • Evaluation of adult patients with known MCA or ICA occlusion
  • Determining eligibility for mechanical thrombectomy in stroke patients
  • Expediting time between CT and CTA scans with prompt LVO notifications (as part of the RapidAI platform)
  • Improving patient outcomes in acute stroke care through faster interventions
  • Aiding in patient selection for stroke clinical trials (e.g., DAWN and DEFUSE 3)

What Physicians Need to Know

Brain MRI/CT Analysis
Rapid ASPECTS is a computer-aided diagnosis (CADx) software device that assists clinicians in assessing and characterizing brain tissue abnormalities using CT image data. It automatically registers images, segments, and analyzes ASPECTS Regions of Interest (ROIs), extracting image data for analysis and computer analytics based on morphological characteristics.
Large Vessel Occlusion Detection
Rapid ASPECTS provides an automated system for scoring non-contrast CT scans in the presence of large vessel occlusions (LVO) based on the Alberta Stroke Program Early CT Score (ASPECTS) system.
ASPECTS Score Automation
Rapid ASPECTS automatically generates an ASPECT score based on the case input file for the physician. This score identifies specific ASPECT regions based on regional imaging features derived from non-contrast computed tomography (NCCT) brain image data. The results are generated according to the Alberta Stroke Program Early CT Score (ASPECTS) guidelines. Studies have shown that with Rapid ASPECTS assistance, scores assigned by non-neuroradiologists were more comparable with the expert reference standard, and overall accuracy improved from 0.72 to 0.82.
Mobile Notification System
Combining AI imaging platforms with mobile technology facilitates awareness across stroke teams to optimize evaluation and treatment decisions. RapidAI software presents imaging data to physicians in a quick and secure manner, facilitating stroke diagnosis and treatment.
Physician Tip

Rapid ASPECTS can help non-neuroradiologists improve their ASPECT scoring of non-contrast CT (NCCT) scans, making scores more consistent and accurate, especially when neuroradiologists are not immediately available. The automated score, combined with a physician's review, can improve the accuracy of ASPECTS score calculation. Physicians can adjust the scores based on other clinical factors through the Rapid Platform User Interface. The system can help identify areas of irreversible brain injury and determine a patient's eligibility for thrombectomy.

RapidAI is an AI-enabled software platform that facilitates the viewing, processing, and analysis of CT imaging to aid clinicians in assessing patients, including those with suspected stroke. It builds on the original RAPID software, which was developed to automate and expedite the postprocessing of CT perfusion imaging. The platform offers an end-to-end portfolio of advanced cerebrovascular imaging analysis products, including Rapid ICH, Rapid ASPECTS, Rapid CTA, Rapid CTP, and Rapid MRI.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Annual subscription model; pricing varies by region, hospital type, modules, and imaging modalities. starts at approximately $12,000 for a single module in the united states.
DeploymentSoftware as a Medical Device (SaMD), delivered via PACS, email, and mobile/web applications (cloud-based).
Mobile AppReal-time collaboration and alerts for urgent cases
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2024-01-19K232156 510(k)Rapid ASPECTS

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Rapid ASPECTS

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Rapid ASPECTS.

View all on YouTube

Frequently Asked Questions

Rapid ASPECTS uses a validated machine-learning algorithm to automatically identify regions of the brain and generate an ASPECT score from non-contrast CT (NCCT) scans. This helps physicians quickly assess early signs of brain infarction and determine a patient's eligibility for thrombectomy. The software aims to standardize and automate the scoring process, which can improve the accuracy of interpretations, especially for less experienced readers, and facilitate faster triage and transfer decisions.
Rapid ASPECTS is FDA-cleared as the first neuroimaging analysis device in the computer-assisted diagnostic software (CADx) category. It has been designed, verified, and validated in compliance with 21 CFR, Part 820.30 requirements and meets the requirements associated with EN ISO 14971:2019 for risk management. It is also CE-marked for use in Europe.
Rapid ASPECTS is intended to assist physician evaluation and is not for primary interpretation of CT images. It has been validated in patients with known Middle Cerebral Artery (MCA) or Internal Carotid Artery (ICA) occlusion prior to ASPECT scoring. Its use in clinical settings other than early brain ischemia (within 6 hours) caused by known ICA or MCA occlusions has not been tested. Additionally, it has been validated for use on GE Lightspeed VCT Scanners.
Yes, other automated ASPECT scoring software exists, such as Brainomix e-ASPECTS and Syngo.via Frontier ASPECTS. Studies have shown comparable accuracy between these applications and expert consensus readings, though Rapid ASPECTS has demonstrated high reliability in some comparative analyses. Other widely used AI systems for stroke triaging include Viz.ai, Aidoc, and Avicenna.AI's CINA.
The pricing model for Rapid ASPECTS is not publicly available. Information regarding specific pricing or cost-effectiveness studies for Rapid ASPECTS against manual interpretation was not identified in the available data.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More from RapidAI

Rapid Enterprise Platform
RapidAI
Cardiology AI
Rapid ICH
RapidAI
Neurology AI

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-08 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.